No Data
Privia Health Is Maintained at Buy by Canaccord Genuity
Privia Health Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26
Privia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational Growth
UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating
Privia Health Group (PRVA) has an average rating of Buy and price targets ranging from $21 to $31, according to analysts polled by Capital IQ. Price: 17.85, Change: -0.18, Percent Change: -1.00
Express News | Privia Health Group Inc : Evercore ISI Cuts Target Price to $23 From $25
Buy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth Outlook